The invention relates to beneficial topical pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions represent opaque emulsion-gels, in which diclofenac is kept fully dissolved.

The present invention relates to a patch for the transdermal release of diclofenac or a pharmaceutically acceptable salt thereof, in particular diethylamine salt, and thiocolchicoside.

The presently disclosed subject matter is directed to methods of treating post-operative pain by administering a combination of a lower than minimum approved dose of diclofenac and beta-cyclodextrin. The presently disclosed subject matter is also directed to methods of treating pain in high risk or obese mammals in need of analgesia.

The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties which may be used for the topical treatment of pain such as in osteoarthritis.

The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.

There is described a pharmaceutical composition with anti-inflammatory and analgesic activity to be delivered by a vaporisation (spray) system for external use comprising, as active ingredient, diclofenac, 2-[(2,6- dichlorophenyl)amino]benzeneacetic acid, preferably as an organic base salt thereof, in particular as a secondary or tertiary amine salt and more particularly as a cyclic, tertiary amine salt. Said active ingredient is dissolved in a volatile silicone in the presence of 2-4C alcohol m...

The subject invention provides improved diclofenac gel formulations.

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine and chemical-pharmaceutical industry, namely to drug preparations used in various spastic intestinal and pancreatic-biliary conditions, especially in irritable bowel syndrome, and to methods for making them. The drug preparation in the form of an orally dispersible tablet characterised by the fact that it contains a combination of hyoscine butyl bromide and diclofenac or its sodium salt in complex with polacrilin potassium in...